SBI Mutual Fund has increased its stake in Biocon to above 5%. On November 11, 2025, the fund acquired 3,70,150 shares, bringing its total holding to 6,68,65,887 shares, representing 5.0013% of the company’s paid-up share capital. This acquisition reflects SBI Mutual Fund’s increased investment in the pharmaceutical company.
SBI MF’s Increased Holding
SBI Mutual Fund’s schemes have collectively acquired 3,70,150 shares of Biocon on November 11, 2025. This acquisition resulted in the fund’s holding exceeding 5% of Biocon’s paid-up share capital. The disclosure was made on November 12, 2025.
Total Shareholding Post Acquisition
Following the recent transaction, SBI Mutual Fund’s total holding in Biocon stands at 6,68,65,887 shares. This represents approximately 5.0013% of Biocon’s total paid-up share capital as of November 11, 2025. This change in shareholding was communicated to the stock exchanges.
Source: BSE
